This protocol is judged by an institutional critique board, an impartial group that critiques any scientific trials involving humans. If a research involves a Agenda I drug, as soon as the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) selection in the FDA.copyright initially t